A Complete Response Induced by 21-Day Sorafenib Therapy in a Patient With Advanced Hepatocellular Carcinoma

Internal Medicine - Japan
doi 10.2169/internalmedicine.52.9340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Sorafenib Continuation or Discontinuation in Patients With Unresectable Hepatocellular Carcinoma After a Complete Response

Oncotarget
Oncology
2015English

A Case of Hepatocellular Carcinoma With Pulmonary Metastasis Who Showed Complete Response by Cytotoxic Chemotherapy After Sorafenib Failure

Journal of Liver Cancer
2017English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Metabolic Complete Response With Vinflunine as Second-Line Therapy in a Kidney-Transplanted Patient With Advanced Urothelial Carcinoma: A Case Report

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Sorafenib-Induced Acute Interstitial Pneumonia in Patients With Advanced Hepatocellular Carcinoma: Report of Three Cases

Clinical Journal of Gastroenterology
MedicineGastroenterology
2012English

Addition of Local Hepatic Therapy to Sorafenib in Patients With Advanced Hepatocellular Carcinoma (Stage BCLC C)

Digestion
Gastroenterology
2014English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy